 |
|
Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea
Hyemin Jeong, Yeong Hee Eun, In Young Kim, Hyungjin Kim, Joong Kyong Ahn, Jaejoon Lee, Eun-Mi Koh, Hoon-Suk Cha
Korean J Intern Med. 2018;33(2):407-416. Published online 2016 Oct 12 DOI: https://doi.org/10.3904/kjim.2016.042
|
|
Citations to this article as recorded by
 Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network
Guillaume Larid, Guy Baudens, Georges Tiemdjo-Djimaffo, Pascal Coquerelle, Vincent Goeb, Marie Hélène Guyot, Laurent Marguerie, Frédéric Maury, Eric Veillard, Eric Houvenagel, Jean-Hugues Salmon, René-Marc Flipo, Elisabeth Gervais
Scientific Reports.2024;[Epub] CrossRef High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis
Dong-Hyuk Moon, Aran Kim, Byung-Wook Song, Yun-Kyung Kim, Geun-Tae Kim, Eun-Young Ahn, Min-Wook So, Seung-Geun Lee
Pharmaceuticals.2023; 16(3): 379. CrossRef Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. A systematic review
Chrysoula G. Gialouri, Maria Pappa, Gerasimos Evangelatos, Elena Nikiphorou, George E. Fragoulis
Autoimmunity Reviews.2023; 22(7): 103357. CrossRef Impact of Infliximab Biosimilar CT-P13 Dose and Infusion Interval on Real-World Drug Survival and Effectiveness in Patients with Ankylosing Spondylitis
Shin-Seok Lee, Tae-Hwan Kim, Won Park, Yeong-Wook Song, Chang-Hee Suh, Soo-Kyoung Kim, Dae-Hyun Yoo
Journal of Clinical Medicine.2021; 10(19): 4568. CrossRef Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis
Se Hee Kim, Hae-Rim Kim, Sang-Heon Lee, Kichul Shin, Hyoun-Ah Kim, Hong Ki Min
Scientific Reports.2021;[Epub] CrossRef The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis
Axel Svedbom, Johan Dalén, Moa Ivergård, Rebekah H. Borse, Christopher M. Black, Karin Luttropp, Sumesh Kachroo
The European Journal of Health Economics.2020; 21(1): 45. CrossRef Frequency of peripheral diseases in Korean patients with ankylosing spondylitis and the effectiveness of adalimumab
Sang‐Hoon Lee, Won Park, Sung Won Lee, Hyun Ah Kim, Jung‐Yoon Choe, Sang‐Heon Lee, Shin‐Seok Lee, Sung‐Hwan Park, Min‐Chan Park, Dong‐Hyuk Sheen, Hye Soon Lee, Yeon‐Ah Lee, Yusun Lee, Tae‐Hwan Kim
International Journal of Rheumatic Diseases.2020; 23(9): 1175. CrossRef Drug Survival of Biologics in Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis of Real-World Evidence
Chia-Ling Yu, Chung-Han Yang, Ching-Chi Chi
BioDrugs.2020; 34(5): 669. CrossRef Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice
Ulf Lindström, Tor Olofsson, Sara Wedrén, Ilia Qirjazo, Johan Askling
Arthritis Research & Therapy.2019;[Epub] CrossRef Adalimumab/etanercept/infliximab
Reactions Weekly.2018; 1698(1): 21. CrossRef Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry
Philip J. Mease, Désirée van der Heijde, Chitra Karki, Mei Liu, Yujin Park, Jeffrey D. Greenberg
Rheumatology and Therapy.2018; 5(2): 537. CrossRef Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis
Atul Deodhar, David Yu
Seminars in Arthritis and Rheumatism.2017; 47(3): 343. CrossRef Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis
Hai Lin, Yi-Zhen Gong
Rheumatology International.2017; 37(8): 1267. CrossRef
|